Literature DB >> 8662159

Sacrococcygeal chordoma: review of 50 consecutive patients.

R Y Chandawarkar1.   

Abstract

Fifty consecutive patients with sacrococcygeal chordomas treated during 1941-1991 at the Tata Memorial Hospital in India were studied retrospectively. Pain was the commonest presenting symptom (82%). An average time lapse of 14 months between the onset of pain and definitive diagnosis emphasizes the importance of a high index of suspicion and prompt use of sophisticated imaging techniques leading to an early diagnosis. All patients underwent a partial sacrococcygectomy, through a sacral approach in 22 patients (44%) and an abdominosacral approach in 28 (56%). Postoperative complications included urinary incontinence (14%), rectal incontinence (6%), hemorrhage (4%), and rectal injury (2%). Radiotherapy offered significant pain relief to patients with widespread recurrence. A total of 38 patients were ambulatory, and 12 needed support. The average disease-free survival was 63 months, and the overall survival was 7 years. Aggressive resection through a combined abdominosacral approach offers the best results. Because postrecurrence salvage rates are poor, the primary surgery must be complete and curative.

Entities:  

Mesh:

Year:  1996        PMID: 8662159     DOI: 10.1007/s002689900110

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  [Primary malignant bone tumors].

Authors:  R von Eisenhart-Rothe; A Toepfer; M Salzmann; J Schauwecker; H Gollwitzer; H Rechl
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

2.  Technique and surgical outcome of total resection of lower sacral tumor.

Authors:  Xiang Yin; Wei-Li Fan; Feng Liu; Jun Zhu; Peng Liu; Jian-Hua Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  SACRAL CHORDOMA.

Authors:  K J Philipose; G Ramdas; Y V Suri; P Takkar; A K Malviya
Journal:  Med J Armed Forces India       Date:  2017-06-08

4.  [Imaging of sacral chordoma: comparison between MRI and CT].

Authors:  C Plathow; M-A Weber; J Debus; H-U Kauczor
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

Review 5.  The biological basis for modern treatment of chordoma.

Authors:  Roberto Jose Diaz; Michael D Cusimano
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

6.  Surgical margins and local control in resection of sacral chordomas.

Authors:  Pietro Ruggieri; Andrea Angelini; Giuseppe Ussia; Maurizio Montalti; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

7.  High expression of survivin in sacral chordoma.

Authors:  Chao Chen; Hui-Lin Yang; Kang-Wu Chen; Gen-Lin Wang; Jian Lu; Quan Yuan; Yong-Ping Gu; Zong-Ping Luo
Journal:  Med Oncol       Date:  2013-03-16       Impact factor: 3.064

8.  Management of sacrococcygeal chordomas.

Authors:  H Atalar; H Selek; Y Yildiz; Y Sağlik
Journal:  Int Orthop       Date:  2006-03-22       Impact factor: 3.075

9.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

10.  Managing bowel and bladder impairments in sacral chordoma patients: a case-based approach.

Authors:  Sasha E Knowlton; Cody Andrews; Corey Bindler; Lisa M Ruppert
Journal:  Spinal Cord Ser Cases       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.